Concepedia

Cheuk Hong Leung

CH

25

Publications

1.7K

Citations

16

H-Index

2017

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Beneficência Portuguesa de São Paulo

The University of Texas Health Science Center at Houston

Cheuk Hong Leung is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2017–2024

25

Publications

25

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 582 citations · Full text

, , +6

Immuno-genomic landscape of osteosarcoma

Chia-Chin Wu, Hannah C. Beird, J. Andrew Livingston et al. · Nature Communications · 2020 · 234 citations · Full text

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt et al. · Nature Medicine · 2023 · 191 citations · Full text

Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study.

Tina Cascone, William Nassib William, Annikka Weissferdt et al. · Journal of Clinical Oncology · 2019 · 142 citations

, , +17

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Tina Cascone, Annikka Weissferdt, Myrna C. B. Godoy et al. · Nature Communications · 2021 · 102 citations · Full text

Rows per page

1–5 of 25